SMSPHARMA.NSSMSPHARMA.NSNSE
Loading
Year-over-year SG&A expense growth
Latest
0.00%
↑ 100% vs avg
Percentile
P33
Within normal range
Average
-5.01%
Historical baseline
| Period | Value |
|---|---|
| Q4 2025 | 0.00% |
| Q3 2025 | 0.00% |
| Q2 2025 | -100.00% |
| Q1 2025 | 0.00% |
| Q4 2024 | 0.00% |
| Q3 2024 | -100.00% |
| Q2 2024 | -16.96% |
| Q1 2024 | 23.66% |
| Q4 2023 | -11.33% |
| Q3 2023 | 12.31% |
| Q2 2023 | 7.03% |
| Q1 2023 | 49.99% |
| Q4 2022 | 33.36% |
| Q3 2022 | -4.01% |
| Q2 2022 | -44.23% |
| Q1 2022 | 12.60% |
| Q4 2021 | 28.06% |
| Q3 2021 | -29.56% |
| Q2 2021 | -39.98% |
| Q1 2021 | 2.64% |
| Q4 2020 | 17.70% |
| Q3 2020 | 3.01% |
| Q2 2020 | -24.33% |
| Q1 2020 | 18.95% |
| Q4 2019 | 2.71% |
| Q3 2019 | -0.54% |
| Q2 2019 | -8.21% |
| Q1 2019 | 15.71% |
| Q4 2018 | 0.74% |
| Q3 2018 | 5.02% |
| Q2 2018 | 0.00% |
| Q1 2018 | 0.00% |
| Q1 2018 | 0.00% |
| Q2 2017 | 0.00% |
| Q1 2017 | 0.00% |
| Q1 2017 | 0.00% |
| Q3 2016 | 0.00% |
| Q2 2016 | -100.00% |
| Q1 2016 | 47.07% |
| Q4 2015 | -1.91% |